Yabao Pharmaceutical Group (600351.SH) has repurchased approximately 20 million shares in total and completed the repurchase plan.

Yabao Pharmaceutical Group (600351.SH) has announced that its share repurchase plan has been completed on March 3, 2025. The company has repurchased approximately 20 million shares, accounting for 2.78% of the total share capital, through a special account for share repurchases using the centralized bidding trading method. The highest purchase price was 6.67 yuan per share, the lowest was 5.78 yuan per share, and the average purchase price was 6.18 yuan per share. The total amount paid for the repurchase was 124 million yuan (excluding transaction costs).